Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
No open-market purchases or sales by Faeth Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Faeth Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −3 vs. Q3 2022
- Shares held
- 2.64M
- −243.6K (−8.4%) vs. Q3 2022
- Total value
- $3.93M
- −$533.3K (−11.9%) vs. Q3 2022
- New holders
- 4
- 5 more added
- Sold out
- 7
- 12 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $68.0M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.2K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.43M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 4 | $0 | 0.00% | −73−94.8% | Reduced |
| Harbour Investments, Inc. | 3 | $4 | 0.00% | 00.0% | Unchanged |
| Fiduciary Alliance LLC | 50 | $75 | 0.00% | +50 | New |
| Wells Fargo & Company | 123 | $183 | 0.00% | +3+2.5% | Added |
| Morgan Stanley | 249 | $371 | 0.00% | −13,320−98.2% | Reduced |
| JPMorgan Chase & Co | 668 | $1.00K | 0.00% | −1,045−61.0% | Reduced |
| UBS Group AG | 1,097 | $1.64K | 0.00% | −12,017−91.6% | Reduced |
| Tower Research Capital LLC (TRC) | 2,110 | $3.00K | 0.00% | −2,727−56.4% | Reduced |
| Banque Cantonale Vaudoise | 3,900 | $6.00K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 11,570 | $17.0K | 0.00% | 00.0% | Unchanged |
| Deuterium Capital Management, LLC | 11,900 | $17.7K | 0.05% | +11,900 | New |
| Raymond James & Associates | 19,000 | $28.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 25,774 | $38.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,049 | $38.8K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 26,060 | $39.0K | 0.01% | +26,060 | New |
| Two Sigma Investments, LP | 31,076 | $46.3K | 0.00% | −4,700−13.1% | Reduced |
| Ergoteles LLC | 34,340 | $51.2K | 0.00% | −55,627−61.8% | Reduced |
| Two Sigma Advisers, LP | 35,400 | $52.7K | 0.00% | −2,500−6.6% | Reduced |
| BlackRock Inc. | 36,873 | $54.9K | 0.00% | −137,077−78.8% | Reduced |
| Western Standard LLC | 46,117 | $68.7K | 0.06% | +46,117 | New |
| Bank of America Corp | 48,681 | $72.5K | 0.00% | +11,775+31.9% | Added |
| Millennium Management LLC | 67,242 | $100.0K | 0.00% | −11,839−15.0% | Reduced |
| Geode Capital Management, LLC | 98,006 | $146.0K | 0.00% | +6,111+6.6% | Added |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 100,000 | $149.0K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 112,900 | $168.2K | 0.00% | −50,000−30.7% | Reduced |
| Renaissance Technologies LLC | 172,554 | $257.0K | 0.00% | −33,246−16.2% | Reduced |
| Vanguard Group Inc | 573,651 | $854.7K | 0.00% | +1950.0% | Added |
| Newtyn Management, LLC | 1,155,561 | $1.72M | 0.36% | +740,561+178.4% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −683,529−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −50,229−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −16,711−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,446−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −361−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −603−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −288−100.0% | Sold out |